Barb; Seems funny on COPD Foundation website they in their drug pipeline talk about three new drugs, CHF6297 a MAP Kinase p38 inhibitor, GS 5745 a MMP9 inhibitor, and GSK2269557 a PK13 inhibitor. All are in trials, but what I can't understand is they had a new drug coming out Solithromycin it did all three of those things and after Phase 3 trials they pulled it for liver toxitity. Can we really trust them? I figure COPD drugs bring big pharma about 35 billion a year, I don't believe they want a cure. They just keep making stronger and stronger relief drugs to sell more.